Skip to main content
Premium Trial:

Request an Annual Quote

PNAS Papers on Kleine-Levin Syndrome GWAS, Non-Coding RNA Methylation Imprinting, More

Editor's Note: Some of the articles described below are not yet available at the PNAS site, but they are scheduled to be posted this week.

An international team led by investigators at Stanford University presents findings from a genome-wide association study focused on a rare condition called Kleine-Levin syndrome (KLS) that is marked by episodes of excess sleep, cognitive impairment, and other symptoms. Using array-based genotyping profiles for 673 individuals over 14 years old with KLS and more than 15,300 unaffected controls from similar ancestral backgrounds, the researchers narrowed in on a KLS-associated region that spanned 20 SNPs in and around the bipolar disorder- and schizophrenia-related gene TRANK1 in the original cohort. The KLS-related region did not track with the condition in another set of 171 KLS cases, they note, though it remained associated in a subset of cases that involved children with difficult births. The authors suggest "variants in the TRANK1 gene region may predispose to KLS when patients have had a difficult birth, suggesting that [the] TRANK1 gene region modulates newborns' response to brain injury, with consequences for mental and neurological health in adulthood."

A team from the US and South Africa report on apparent ties between maternal age and alcohol consumption and DNA methylation-based imprinting on nc886 — a non-coding RNA that falls in a stretch of sequence that is silenced on the maternally inherited allele in most individuals, despite being methylated in human eggs. The researchers relied on high-resolution melt curve analyses to profile nc886 DNA methylation in on newborn blood spot or cord blood samples from 1,132 South African mother-child pairs, uncovering a maternal age-associated rise in nc886 and a dip in imprinting that coincided with alcohol consumption. "[W]e demonstrate that alcohol consumption but not cigarette smoking is associated with a lower frequency of imprinting," they report. "While most studies focus on the post-conceptional developmental time, our work indicates that maternal age and exposures the year prior to pregnancy may alter the epigenome and therefore the developing child."

Researchers from Japan, China, and elsewhere explore turnip mosaic potyvirus (TuMV) pathogen spread in Brassica vegetables and other plants, using genome sequence data and phylogenetics. Based on whole-genome sequence data for 579 TuMV isolates collected from sites in Europe and Asia over several decades, together with hundreds more partial pathogen sequences, the team used phylogenetics and molecular clock profiling to assess Eurasian TuMV emergence and spread, which coincided to some extent with trade along with Silk Road. "Many crops are believed to have spread to East Asia via the Silk Road," the authors write. "We found that TuMV was able to infect Brassica plants in the 17th century CE and spread to Eastern Eurasia over the past few centuries."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.